Ocugen (FRA:2H51) Cyclically Adjusted Book per Share: €-0.41 (As of Mar. 2026)


FRA:2H51 Ocugen Inc FRA:2H51
19 GF Score
Price €1.26
GF Value €0.66
Valuation Significantly Overvalued
! 4 Warning Signs
View Full Analysis

What is Ocugen Cyclically Adjusted Book per Share?

Ocugen FRA:2H51 -3.24% 19 Cyclically Adjusted Book per Share is €-0.41 as of Mar. 2026. GuruFocus rates FRA:2H51 with a GF Score™ of 19/100 and a GF Value™ of €0.66 (Significantly Overvalued). The stock has 4 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

Ocugen's adjusted book value per share for the three months ended in Mar. 2026 was €0.015. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is €-0.41 for the trailing ten years ended in Mar. 2026.

During the past 12 months, Ocugen's average Cyclically Adjusted Book Growth Rate was -102.50% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

As of today (2026-07-12), Ocugen's current stock price is €1.256. Ocugen's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2026 was €-0.41. Ocugen's Cyclically Adjusted PB Ratio of today is .

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Ocugen was 0.92. The lowest was 0.02. And the median was 0.08.


Ocugen  (FRA:2H51) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Ocugen was 0.92. The lowest was 0.02. And the median was 0.08.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


Ocugen Cyclically Adjusted Book per Share Related Terms


Ocugen Cyclically Adjusted Book per Share Historical Data

* Premium members only.

The historical data trend for Ocugen's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Ocugen Cyclically Adjusted Book per Share Chart

Ocugen Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 18.02 28.15 2.49

Ocugen Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 18.15 10.37 5.46 2.49 -0.41

FRA:2H51 vs STRO, NGNE, CBIO: Cyclically Adjusted Book per Share Comparison

For the Biotechnology subindustry, Ocugen's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Ocugen Cyclically Adjusted PB Ratio vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Ocugen's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Ocugen's Cyclically Adjusted PB Ratio falls into.


FRA:2H51
19GF Score
Ocugen Inc FRA:2H51
Cyclically Adjusted Book per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Ocugen Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Ocugen's adjusted Book Value per Share data for the three months ended in Mar. 2026 was:

Adj_Book= Book Value per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=0.015/330.2130*330.2130
=0.015

Current CPI (Mar. 2026) = 330.2130.

Ocugen Quarterly Data

Book Value per Share CPI Adj_Book
201606 51.905 241.018 71.114
201609 13.570 241.428 18.560
201612 37.390 241.432 51.139
201703 17.667 243.801 23.929
201706 1.933 244.955 2.606
201709 -10.626 246.819 -14.216
201712 -23.222 246.524 -31.105
201803 -34.052 249.554 -45.058
201806 -41.798 251.989 -54.773
201809 -14.223 252.439 -18.605
201812 -0.390 251.233 -0.513
201903 -3.105 254.202 -4.033
201906 -4.900 256.143 -6.317
201909 -1.187 256.759 -1.527
201912 0.188 256.974 0.242
202003 0.125 258.115 0.160
202006 0.096 257.797 0.123
202009 0.076 260.280 0.096
202012 0.096 260.474 0.122
202103 0.208 264.877 0.259
202106 0.486 271.696 0.591
202109 0.458 274.310 0.551
202112 0.425 278.802 0.503
202203 0.552 287.504 0.634
202206 0.499 296.311 0.556
202209 0.444 296.808 0.494
202212 0.315 296.797 0.350
202303 0.313 301.836 0.342
202306 0.253 305.109 0.274
202309 0.213 307.789 0.229
202312 0.145 306.746 0.156
202403 0.108 312.332 0.114
202406 0.061 314.175 0.064
202409 0.126 315.301 0.132
202412 0.097 315.605 0.101
202503 0.050 319.799 0.052
202506 0.009 322.561 0.009
202509 0.010 324.800 0.010
202512 -0.033 324.054 -0.034
202603 0.015 330.213 0.015

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

What does a Cyclically Adjusted Book per Share of €-0.41 mean?
Ocugen (FRA:2H51) has a Cyclically Adjusted Book per Share of €-0.41 as of Mar. 2026. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Ocugen and its competitors.
Is Ocugen's Cyclically Adjusted Book per Share too high?
Ocugen's current Cyclically Adjusted Book per Share is €-0.41. Overall, Ocugen has a GF Score™ of 19/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Ocugen's Cyclically Adjusted Book per Share compare to STRO and NGNE?
Ocugen's Cyclically Adjusted Book per Share of €-0.41 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Book per Share for a Biotechnology company?
A good Cyclically Adjusted Book per Share depends on the Biotechnology industry context. However, Cyclically Adjusted Book per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Book per Share mean?
A high Cyclically Adjusted Book per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Ocugen and its competitors. Ocugen's current Cyclically Adjusted Book per Share is €-0.41. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ocugen stock overvalued right now?
Based on GuruFocus' analysis, Ocugen (FRA:2H51) is currently considered Significantly Overvalued. The stock's GF Value™ is €0.66, compared to a current price of €1.26 — trading 90.3% above its estimated fair value. The current Cyclically Adjusted Book per Share is €-0.41. Ocugen's overall GF Score™ is 19/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Book per Share calculated?
Cyclically Adjusted Book per Share is calculated from a company's financial statements. For Ocugen (FRA:2H51), the current Cyclically Adjusted Book per Share is €-0.41 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Ocugen (FRA:2H51) Overvalued in 2026?

Based on GuruFocus' analysis, Ocugen stock appears to be overvalued. The current stock price of €1.26 is trading 90.3% above its estimated GF Value™ of €0.66. GuruFocus considers Ocugen to be Significantly Overvalued.

Key valuation signals for FRA:2H51:

  • Cyclically Adjusted Book per Share: €-0.41
  • GF Value™: €0.66 vs. price of €1.26 (90.3% above fair value)
  • GF Score™: 19/100 with 4 warning signs

No single metric tells the full story. See the FRA:2H51 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Ocugen Business Description

Address 11 Great Valley Parkway, Malvern, PA, USA, 19355
Ocugen Inc company focused on discovering, developing, and commercializing novel gene and cell therapies and vaccines that improve health and offer hope for patients across the globe. The company's pipeline includes Modifier Gene Therapy Platform, Novel Biologic Therapy for Retinal Diseases, Regenerative Medicine Cell Therapy Platform, Inhaled Mucosal Vaccine Platform. The company is developing a modifier gene therapy platform designed to fulfill unmet medical needs related to retinal diseases, including inherited retinal diseases ("IRDs"), such as RP, LCA, Stargardt disease, and multifactorial diseases such as dAMD and Geographic Atrophy ("GA").
19GF Score

Get the complete analysis for FRA:2H51

Cyclically Adjusted Book per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€1.26
Price
€0.66
GF Value